The biotechnology company Microcoat, based in Bernried at the Starnberg See, celebrates its 30th anniversary. The B2B company has developed from a microplate specialist into a medium-sized company with a broad product portfolio for customers in the biotechnology and pharmaceutical industries and services in the areas of custom development, contract manufacturing and laboratory services, 230 employees and its own facilities - equipped with state-of-the-art technology and a production facility that is independent of fossil fuels and complies with the latest energy standards. Microcoat's 30th anniversary was now celebrated with an anniversary party.
Microcoat is a B2B company dedicated to offering a wide range of individual and specialized services for the diagnostic and pharmaceutical industry at the highest quality levels. As a spin-off of Boehringer Mannheim GmbH, the company "Microcoat Biotechnologie GmbH" was founded in April 2002. At that time, the company was focused on the main technology of coating microtiter plates. Today Microcoat is a medium-sized company with more than 230 employees. For the future, the company remains committed to its mission: To remain innovative, to continue to grow with customers and partners and to position itself for the future in accordance with the latest regulations.
The 30 years were now duly celebrated with an anniversary party. Invited guests came to Bernried, caught a glimpse of the new company premises currently under construction and summed up the development of the company and the biotechnology industry in the panel discussion.
“30 years ago, I noticed directly at my employer Boehringer Mannheim in Tutzing that there was a market for the outsourcing for coating of microtiter plates. So, I first started in the kitchen, applying microtiter plates with streptavidin”,
said Dr. Wolfgang Mutter, cofounder of Microcoat Biotechnologie GmbH.
30 years later, the company has grown from originally 3 employees to almost 250 employees. A settlement in the Bernried industrial area at the Starnberg See enabled the professionalization of the originally as OHG funded company in a professional and growing environment in the metropolitan area of Munich. Initially, the first building was built in 1996, which was then extended by the second building in 2002. In the meantime, the park has grown to four buildings. The third building with approx. 3500m2 of usable space was inaugurated as a laboratory building in 2021. An office building with conference rooms is under construction and is planned to be occupied in spring 2023. The last two buildings are equipped with state-of-the-art technology and enable production independent from fossil raw materials.
“After 30 years, the production of microtiter plates is still part of our portfolio, but our business has grown massively in the areas of Customer Development, Contract Manufacturing and Laboratory Services. Thanks to the appropriate certifications, we can offer our customers high-quality products and services in the fields of biotechnology and pharmaceuticals”,
said Dr. Sonja Molinaro, Dr. Johannes Reich and Dr. Katharina Heinerich, the Managing Directors of Microcoat.
Microcoat acts in the Business Segment „Contract Manufacturing“ as approved OEM manufacturer for diagnostic test kits, bulk and finished components according to ISO and IVD standards. In the Business Segment „Custom Development“ innovative diagnostic immuno- and molecular assays, test components and new test formats are developed according to customer`s requirements. In the Business Segment „Laboratory Services“ the services range from large molecule drug development according to GLP and GCP standards including development, transfer and validation of PK, ADA and Biomarker assays on various platforms.
Special service is provided in the fields of endotoxin and pyrogen testing (exploratory or GMP).